protein tyrosine phosphatase

Search Term: protein tyrosine phosphatase

Overview

Individual Studies
OMIM - Congenital disorder Homo sapiens This study contains curated human phenotype data extracted from OMIM. Additional computational processing and curation of the phenotype data was performed to further organize and group data from related phenotypes into unifying disease categories. Source: NextBio Library/Mutation and Phenotypic data Total # Biosets: 614	Reduced levels of CD45 (protein tyrosine phosphatase) protect mice from Ebola virus Mus musculus RNA expression in CD45 100% and 62% mice were compared at each time point: days 0, 1, 3, 5, and 7, using an empirical Bayes procedure. From 3 to 8 biological replicates were in each group. Samples for days 9, 11, and 13 (4 biological replicates each) were also available for only CD45 62%. Source: NextBio Library/Immune response and infection Total # Biosets: 16

Thought leaders and organizations working on research involving protein tyrosine phosphatase.

View All Author icon

View All Clinical trial sponsors icon

View All Affiliations icon

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

conditions: Type 2 Diabetes Mellitus

interventions: ISIS 113715
Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer

conditions: Brain and Central Nervous System Tumors ; Melanoma (Skin)

interventions: recombinant interferon alfa-2b ; cisplatin ; sodium stibogluconate ; temozolomide ; vinblastine ; gene expression analysis ; immunoenzyme technique ; laboratory biomarker analysis ; pharmacological study

No NextBio groups were found for “protein tyrosine phosphatase”.
Be the first to start a group and share your interests with others within the NextBio community.